Published in Transplant Proc on March 01, 2005
Optimal Decisions for Organ Exchanges in a Kidney Paired Donation Program. Stat Biosci (2014) 0.82
Donor exchange programs in kidney transplantation: rationale and operational details from the north central donor exchange cooperative. Am J Kidney Dis (2010) 0.79
Past, present and future of kidney paired donation transplantation in India. World J Transplant (2017) 0.75
Incentive compatibility in kidney exchange problems. Health Care Manag Sci (2009) 0.75
A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation. Transplantation (1999) 2.27
Variability of relative blood volume during haemodialysis. Nephrol Dial Transplant (2000) 2.10
Sequential measurements of soluble interleukin 2 receptor levels in plasma of heart transplant recipients. Transplantation (1990) 2.06
[Twenty-five years of cyclosporin use in transplantation medicine]. Ned Tijdschr Geneeskd (2003) 1.94
A criminological perspective: why prohibition of organ trade is not effective and how the Declaration of Istanbul can move forward. Am J Transplant (2011) 1.92
Randomized phase 2b trial of tofacitinib (CP-690,550) in de novo kidney transplant patients: efficacy, renal function and safety at 1 year. Am J Transplant (2012) 1.79
Donor-specific T-cell reactivity identifies kidney transplant patients in whom immunosuppressive therapy can be safely reduced. Transplantation (2000) 1.55
Contrasting response to cyclosporin in refractory nephrotic syndrome. Clin Nephrol (1989) 1.48
Ultrafiltration improves aortic compliance in haemodialysis patients. J Hum Hypertens (2005) 1.46
Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reduction. Transplantation (2000) 1.43
Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacities. Stem Cells Dev (2007) 1.43
The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation. Clin Pharmacol Ther (1998) 1.42
The TNF-alpha system in heart failure and after heart transplantation: plasma protein levels, mRNA expression, soluble receptors and plasma buffer capacity. Eur Heart J (1999) 1.42
Successful treatment of Kaposi's sarcoma in a renal allograft recipient. Nephrol Dial Transplant (1995) 1.41
Inflammatory conditions affect gene expression and function of human adipose tissue-derived mesenchymal stem cells. Clin Exp Immunol (2010) 1.41
Hepatitis B and hemodialysis: the impact of universal precautions in preventing the transmission of bloodborne viruses. Infect Control Hosp Epidemiol (1998) 1.41
Functional responses of T cells blocked by anti-CD25 antibody therapy during cardiac rejection. Transplantation (2000) 1.40
Increase in blood volume during dialysis without ultrafiltration. Blood Purif (2001) 1.40
[More potential organ donors than actual donations in 52 intensive-care units in the Netherlands, 2001-2004]. Ned Tijdschr Geneeskd (2007) 1.40
Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppression. Transplantation (2001) 1.39
[Favourable results of the first 2 years of the Dutch paired, living donor, kidney exchange programme]. Ned Tijdschr Geneeskd (2007) 1.39
[Kidney transplantation: more kidneys from living donors, individualised immunosuppression and better results]. Ned Tijdschr Geneeskd (2003) 1.38
Recombinant leucocyte interferon A induces steroid-resistant acute vascular rejection episodes in renal transplant recipients. Lancet (1984) 1.37
Auxiliary partial liver transplantation for end-stage chronic liver disease. N Engl J Med (1988) 1.14
Detection of multiple 'Ebnotypes' in individual Epstein-Barr virus carriers following lymphocyte transformation by virus derived from peripheral blood and oropharynx. J Gen Virol (1994) 1.12
Proteinuria after renal transplantation affects not only graft survival but also patient survival. Transplantation (2001) 1.10
Phase 1 dose-escalation study of CP-690 550 in stable renal allograft recipients: preliminary findings of safety, tolerability, effects on lymphocyte subsets and pharmacokinetics. Am J Transplant (2008) 1.05
Double-blind study of leucocyte interferon administration in chronic HBsAg-positive hepatitis. Lancet (1980) 1.02
Specific lysis of an iliofemoral thrombus by administration of extrinsic (tissue-type) plasminogen activator. Lancet (1981) 1.01
The superior results of living-donor renal transplantation are not completely caused by selection or short cold ischemia time: a single-center, multivariate analysis. Transplantation (2003) 1.01
Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts. N Engl J Med (1989) 1.01
Antiviral effect of interferon in vivo may be mediated by the host. Nature (1979) 1.00
Changes in immunological parameters after conversion from cyclosporine A to azathioprine in renal transplant recipients. Int J Immunopharmacol (1989) 0.99
Ischemia times and donor serum creatinine in relation to renal graft failure. Transplantation (2003) 0.99
Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome. Clin Sci (Lond) (1992) 0.98
Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine, but not azathioprine. Transplantation (1986) 0.98
Production and initial characterization of rat interferon. J Gen Virol (1980) 0.98
Follicular T helper cells and humoral reactivity in kidney transplant patients. Clin Exp Immunol (2015) 0.96
Tacrolimus predose concentrations do not predict the risk of acute rejection after renal transplantation: a pooled analysis from three randomized-controlled clinical trials(†). Am J Transplant (2013) 0.96
Mycophenolic acid plasma concentrations in kidney allograft recipients with or without cyclosporin: a cross-sectional study. Nephrol Dial Transplant (1999) 0.96
Technical considerations and pitfalls in laparoscopic live donornephrectomy. Surg Endosc (2002) 0.95
Donor-derived mesenchymal stem cells remain present and functional in the transplanted human heart. Am J Transplant (2008) 0.95
Effect of cyclosporine on mycophenolic acid trough levels in kidney transplant recipients. Transplantation (1999) 0.95
Long-term graft survival after urological complications of 695 kidney transplantations. J Urol (2001) 0.94
Persistent Epstein-Barr virus infection and a histiocytic sarcoma in a renal transplant recipient. Cancer (1985) 0.94
Hypotension during hemodialysis results from an impairment of arteriolar tone and left ventricular function. Clin Nephrol (2005) 0.93
The effect of low and ultra-low dosages Thymoglobulin on peripheral T, B and NK cells in kidney transplant recipients. Transpl Immunol (2012) 0.93
Coronary artery disease after heart transplantation: timing of coronary arteriography. J Heart Lung Transplant (1993) 0.92
Influenza vaccination in dialysis and transplant patients. Antiviral Res (1985) 0.92
Immunosuppression should be stopped in patients with renal allograft failure. Clin Transplant (2001) 0.91
Long-term follow-up of a randomized trial comparing laparoscopic and mini-incision open live donor nephrectomy. Am J Transplant (2010) 0.91
The Jak inhibitor CP-690,550 preserves the function of CD4CD25FoxP3 regulatory T cells and inhibits effector T cells. Am J Transplant (2010) 0.91
The calcineurin inhibitor tacrolimus allows the induction of functional CD4CD25 regulatory T cells by rabbit anti-thymocyte globulins. Clin Exp Immunol (2010) 0.90
Trivalent influenza vaccine in patients on haemodialysis: impaired seroresponse with differences for A-H3N2 and A-H1N1 vaccine components. Vaccine (1987) 0.90
A controlled study on the effect of mannitol on immediate renal function after cadaver donor kidney transplantation. Transplantation (1983) 0.89
Infections after renal allograft failure in patients with or without low-dose maintenance immunosuppression. Transplantation (1997) 0.89
Passive immunization against cytomegalovirus in allograft recipients. The Rotterdam Heart Transplant Program experience. Infection (1993) 0.89
Live donor nephrectomy and return to work: does the operative technique matter? Surg Endosc (2003) 0.89
Successful expansion of the living donor pool by alternative living donation programs. Am J Transplant (2009) 0.89
CD4+CD25bright+ regulatory T cells can mediate donor nonreactivity in long-term immunosuppressed kidney allograft patients. Am J Transplant (2006) 0.89
Human adipose-tissue derived mesenchymal stem cells induce functional de-novo regulatory T cells with methylated FOXP3 gene DNA. Clin Exp Immunol (2013) 0.88
The detection of cytotoxic T cells with high-affinity receptors for donor antigens in the transplanted heart as a prognostic factor for graft rejection. Transplantation (1993) 0.87
Immunological aspects of allogeneic and autologous mesenchymal stem cell therapies. Hum Gene Ther (2011) 0.87
Home-based family intervention increases knowledge, communication and living donation rates: a randomized controlled trial. Am J Transplant (2014) 0.87
Addition of isradipine (Lomir) results in a better renal function after kidney transplantation: a double-blind, randomized, placebo-controlled, multi-center study. Transplantation (2000) 0.87
Laparoscopic versus open donor nephrectomy: ureteral complications in recipients. Urology (2004) 0.87
Posttransplantation encapsulating peritoneal sclerosis contributes significantly to mortality after kidney transplantation. Am J Transplant (2011) 0.87
Living kidney donors: impact of age on long-term safety. Am J Transplant (2011) 0.87
TGF-beta1 gene polymorphisms in patients with end-stage heart failure. J Heart Lung Transplant (2001) 0.86
T cells activate the tumor necrosis factor-alpha system during hemodialysis, resulting in tachyphylaxis. Kidney Int (2001) 0.86
Human adipose tissue-derived mesenchymal stem cells abrogate plasmablast formation and induce regulatory B cells independently of T helper cells. Stem Cells (2015) 0.86
A NOVel ELISPOT assay to quantify HLA-specific B cells in HLA-immunized individuals. Am J Transplant (2012) 0.85
Pulsed-wave transmitral Doppler do not diagnose moderate acute rejection after heart transplantation. J Heart Lung Transplant (1993) 0.85
Fibroblast interferon in HBsAg-positive chronic active hepatitis. Lancet (1977) 0.85
Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome. Ren Fail (1997) 0.85
A controlled trial comparing two doses of cyclosporine in conjunction with mycophenolate mofetil and corticosteroids. J Am Soc Nephrol (2001) 0.85
The direct and indirect allogeneic presentation pathway during acute rejection after human cardiac transplantation. Clin Exp Immunol (2005) 0.85
The vanishing importance of age in renal transplantation. Transplantation (1999) 0.85
Decreased antigen-specific T-cell proliferation by moDC among hepatitis B vaccine non-responders on haemodialysis. Clin Exp Med (2007) 0.85
For love or money? Attitudes toward financial incentives among actual living kidney donors. Am J Transplant (2010) 0.85
The effects of renal transplantation on circulating dendritic cells. Clin Exp Immunol (2005) 0.84
A realistic proposal--incentives may increase donation--we need trials now! Am J Transplant (2012) 0.84
Value of booster immunisation with influenza vaccine in patients undergoing haemodialysis. Br Med J (Clin Res Ed) (1987) 0.84
Recovery of failing liver after auxiliary heterotopic transplantation. Lancet (1990) 0.84
Incidence of osteonecrosis after renal transplantation. Acta Orthop Scand (1985) 0.84
Ureter obstruction as a complication of Wegener's granulomatosis. Eur Urol (1985) 0.84
TNF-alpha: mRNA, plasma protein levels and soluble receptors in patients on chronic hemodialysis, on CAPD and with end-stage renal failure. Clin Nephrol (2000) 0.84
Indirect enzyme-linked immunosorbent assay for immunoglobulin G and four immunoassays for immunoglobulin M to Toxoplasma gondii in a series of heart transplant recipients. J Clin Microbiol (1989) 0.84
Stimulation of immune-competent cells in vitro by human cardiac valve-derived endothelial cells. Ann Thorac Surg (1995) 0.84
Cytomegalovirus seronegative heart transplant recipients. Prophylactic use of anti-CMV immunoglobulin. Chest (1990) 0.83
Simulation study of the intercompartmental fluid shifts during hemodialysis. ASAIO J (2000) 0.83
Clinical and biochemical characteristics of collapsed ultra-marathon runners. Med Sci Sports Exerc (1994) 0.83
Cytomegalovirus contributes partly to uraemia-associated premature immunological ageing of the T cell compartment. Clin Exp Immunol (2013) 0.83
Cytokine gene expression profiles in human endomyocardial biopsy (EMB) derived lymphocyte cultures and in EMB tissue. Transpl Int (1994) 0.83
[Donor nephrectomy: less fatigue and better quality of life following laparoscopic kidney removal compared with an open procedure by mini-incision: blind randomised study]. Ned Tijdschr Geneeskd (2007) 0.83
Quantitative relationship between HBeAg and DNA polymerase activity in sera from patients with chronic active hepatitis during a three-month period. J Med Virol (1980) 0.83
Unusual presentation of herpes virus infections in renal transplant recipients exposed to high mycophenolic acid plasma concentrations. Transpl Infect Dis (2003) 0.82
A randomized trial comparing safety and efficacy of OKT3 and a monoclonal anti-interleukin-2 receptor antibody (BT563) in the prevention of acute rejection after heart transplantation. Transplantation (1996) 0.82
Encouraging psychological outcomes after altruistic donation to a stranger. Am J Transplant (2010) 0.82